Skip to main content

Table 1 Characteristics of studies that provided genotype frequencies evaluating the effects of MCP-1 rs1024611 polymorphism on DN and T2DM risk

From: Association between the MCP-1 -2518 A > G (rs1024611) polymorphism and susceptibility to type 2 diabetes mellitus and diabetic nephropathy: a meta-analysis

No

First author, year

Country

Ethnicity

Sample sizea

T2DMb

DNc

Controld

HWE(T2DM/ Control)

NOS score

1

Simeoni, 2004 [25]

Germany

Caucasians

632/-/2568

363/222/47

-

1335/1043/190

-/0.482

8

2

Joo, 2007 [19]

Korea

Asians

169/164/-

23/78/68

26/73/65

-

0.933/-

7

3

Moon, 2007 [23]

Korea

Asians

112/112/230

11/50/51

16/61/35

41/102/87

0.804/0.249

8

4

Chen, 2007 [15]

China (Hunan)

Asians

86/94/102

24/40/22

24/44/26

31/47/24

0.521/0.454

6

5

Karadeniz, 2010 [20]

Turkey

Caucasians

43/43/105

26/17/0

24/19/0

49/44/12

0.332/0.659

7

6

Wu, 2011 [28]

China (Tianjin)

Asians

56/56/50

5/25/26

13/25/18

9/22/19

0.771/0.556

7

7

Jing, 2011 [18]

China (Jiangsu)

Asians

416/-/416

50/274/92

-

67/212/137

-/0.318

8

8

Jeoh, 2013 [17]

Korea

Asians

399/191/-

50/349*

28/163*

-

-

7

9

Grzegorzewska, 2014 [16]

Poland

Caucasians

-/222/437

-

104/97/21

225/177/35

-/0.982

8

10

Raina, 2021 [24]

India

Asians

444/354/515

210/204/30

138/171/45

238/236/41

0.069/0.095

8

11

Xu, 2015 [29]

China (Hubei)

Asians

50/-/50

16/20/14

-

18/19/13

-/0.100

7

12

Ma, 2016 [22]

China (Zhejiang)

Asians

208/-/209

66/102/40

-

46/93/70

-/0.156

8

13

Ma, 2017 [21]

China (Gansu)

Asians

30/-/69

7/13/10

-

13/36/20

-/0.652

7

14

Su, 2018 [26]

China (Hebei)

Asians

135/-/149

18/62/55

-

26/66/57

-/0.688

8

15

Wang, 2019 [27]

China (Jiangsu)

Asians

52/60/78

18/22/12

10/25/25

30/32/16

0.304/0.179

7

16

Cheng, 2019 [14]

China (Zhejiang)

Asians

99/-/109

21/51/27

-

16/54/39

-/0.699

7

  1. Abbreviations: T2DM Type 2 diabetes mellitus, DN Diabetic nephropathy, HWE Hardy–Weinberg equilibrium, NOS Newcastle–Ottawa scale
  2. - Not available
  3. * Total number of AG + GG
  4. a Total participants in the T2DM, DN, and control groups, respectively
  5. b Number of AA, AG, and GG genotypes in the T2DM group
  6. c Number of AA, AG, and GG genotypes in the DN group
  7. dNumber of AA, AG, and GG genotypes in the control group